IRBESARTAN-HCT Mepha cpr pell 300/12.5 28 pce

7680614970031 CH-61497 C09DA04 02.07.2.
IRBESARTAN-HCT Mepha cpr pell 300/12.5 28 pce
IRBESARTAN-HCT Mepha cpr pell 300/12.5 28 pce
1 / 2
google

Details

Product number
6149702
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
irbesartanum 300.0 mg, hydrochlorothiazidum 12.5 mg, povidonum, amylum pregelificatum, poloxamerum 188, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.51 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 6000, macrogolum 400, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), pro compresso obducto.

Articles (1)

Irbesartan-HCT-Mepha 300mg/12.5mg, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
25/07/2025
Professional SmPC
Français
25/07/2025
Professional SmPC
Italien
25/07/2025
Patient information leaflet
Allemand
23/07/2025
Patient information leaflet
Français
23/07/2025
Patient information leaflet
Italien
23/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
12.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.51 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 30.00
Specialties list
Yes
Generic
Yes
SL addition date: 01/03/2014

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
61497
Drug name
Irbesartan-HCT-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
C09DA04
Authorization status
Z
Dispensation category
B
First authorization
08/02/2011
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine
Field of application
Hypertonie essentiell

Packaging details

Description (FR)
IRBESARTAN-HCT Mepha cpr pell 300/12.5 28 pce
Description (DE)
IRBESARTAN-HCT Mepha Filmtabl 300/12.5 28 Stk
Market launch
08/02/2011
Narcotic (BTM)
No

Original drug

CoAprovel, comprimés filmés
CHF 27.45
View original

Other packaging sizes

IRBESARTAN-HCT Mepha cpr pell 150/12.5 28 pce
28 TABL
View
IRBESARTAN-HCT Mepha cpr pell 150/12.5 98 pce
98 TABL
View
IRBESARTAN-HCT Mepha cpr pell 300/12.5 98 pce
98 TABL
View
IRBESARTAN-HCT Mepha cpr pell 300/25 28 pce
28 TABL
View
IRBESARTAN-HCT Mepha cpr pell 300/25 98 pce
98 TABL
View